The ADDF accelerates the discovery of drugs to prevent and treat Alzheimer's disease through research funding and portfolio management.
The Alzheimer's Drug Discovery Foundation (ADDF) is dedicated to advancing the discovery of drugs to prevent and treat Alzheimer's disease. ADDF funds research programs focused on drug development, biomarkers, and prevention strategies. In 2024, ADDF catalyzed significant breakthroughs, including major investments in scalable blood tests and the cataloging of Alzheimer's biomarkers. The foundation also marked the 10th anniversary of the Goodes Prize and celebrated the FDA approval of Kisunla (Donanemab). ADDF's diverse portfolio is one of the largest worldwide, emphasizing lifestyle interventions and innovative diagnostics.
PsychoPy is a free and open-source software platform for creating psychological experiments, with tools for precise timing, hardware integration, and web-based studies.
Explore the Human Behavior category on Medical School TV for valuable insights, educational videos, and resources related to understanding human behavior in medical contexts.
Explore a wide range of psychology-related resources from Cambridge University Press. The site offers journals, books, and online resources covering various aspects of psychology, including research, practice, and education. Browse all available academic journals, books and articles at Cambridge University Press.